Global Influenza Drug Market 2019: Size, Share, Scope, Growth Opportunities Analysis By ADMA Biologics, Inc., Shionogi Inc., F. Hoffmann-La Roche Ltd, Cipla Inc., GlaxoSmithKline Plc, Teva Pharmaceutical Industries Ltd., And Others

Influenza Drug Market

Global influenza drug market to grow with a steady CAGR of 2.1% and is estimated to reach USD 2.05 billion by 2026. The market report focuses on current market status, regional, national and international level market and in-depth study report that offers granular analysis of the market share, manufacturers, product type, applications, technological advancement, and geographic regions. Market basic factors covered in this report includes: Market overview, definitions, and classifications, and industry chain overview. The report predicts future market orientation for the forecast period from 2019 to 2026 with the help of past and current market values.

 Get a Free Sample Report Now @

Influenza (the flu) is a contagious viral infection disease that affect mainly upper respiratory system more specifically nose, throat and lungs. It can cause mild to severe illness and can be fatal. People who have weakened immune system due to drugs or other illness and people who are 65 or older are at high risk of influenza infection. The patients may experience high fever, chills, sweat, cough, nasal congestion and sore throat. Finally, the report features business strategy of industry key players along with their strengths and weaknesses. Various regulatory organizations were used as a data sources during the report development. The report was prepared using exclusive research on built up and developing market players. The report helps the consumer and other firms by providing a comprehensive examination using which they can organize a full-fledged plan for the upcoming period.

Key Market Competitors: Global Influenza Drug Market

Few of the major competitors are ADMA Biologics, Inc., Shionogi Inc., F. Hoffmann-La Roche Ltd, Cipla Inc., GlaxoSmithKline Plc, Teva Pharmaceutical Industries Ltd, Novartis AG, Sun Pharmaceutical Industries Ltd, Sanofi, AstraZeneca, Mitsubishi Chemical Holdings Corporation, Biondvax, BioDiem, FluGen, Inc., Altimmune, Inc., Adamas Pharmaceuticals, Inc., CSL Limited, Daiichi Sankyo Company, Limited and among others.

Enquire here:

The report performs the study of market drivers and market restraints thoroughly along with the analysis of the market structure. This market report endows with the plentiful insights and business solutions that will help to stay ahead of the competition. A class and transparency is strictly maintained while carrying out research studies of this report to offer an exceptional market research report for a specific niche. Businesses can achieve better insights to drive the business into right direction with the different segments covered in the market research report. This market analysis examines various segments which help for the quickest development amid the estimated forecast frame.

Major Market Drivers & Restraints are as follows:

  • Increasing prevalence of Influenza disease worldwide
  • Accelerating demand of treatment and novel therapies
  • Rising awareness about treatment and technological advancement is driving the growth of market
  • Effective treatment is either unavailable or unaffordable
  • Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market
  • Insufficient awareness about influenza treatment in some developing countries

 Market Segmentation:  Global Influenza Drug Market

By Type

  • Influenza A viruses
  • Influenza B viruses
  • Influenza C virus

By Treatment Type

  • Medication
  • Chemoprophylaxis
  • Others

By Mechanism of Action Type

  • Cap-dependent endonuclease inhibitor
    • Daloxavir
  • Neuraminidase inhibitor
    • Oseltamivir
    • Zanamivir
    • Peramivir
    • Laninamivir octanoate
  • Matrix-2 (M2) protein inhibitor
    • Amantadine
  • Viral uncoating inhibitors
    • Rimantadine
  • Immunomodulators
    • Inosine
  • Nonsteroidal anti-inflammatory drug
    • Aspirin
    • Ibuprofen
    • celecoxib
  • Alpha-adrenergic receptors agonist
    • Pseudoephedrine
  • N-Methyl-D-aspartate receptor inhibitor
    • Guaifenesin

By Vaccine Type

  • Quadrivalent
    • Fluarix
    • Fluzone
    • FluLaval
    • FluMist

Speak to our analyst and gain crucial industry insights that will help your business grow.

Company Analysis:                                            

Global influenza drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of influenza drug market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.


Data Bridge Market Research
Tel: +1-888-387-2818



Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *